Can Public Universities Require Covid-19 Vaccines? Former Mayor Paul Johnson Weighs in | Interview
Join The Conversation! | https://trialsitenews.com/ Can Public Universities Require Covid-19 Vaccines? Former Mayor and HealthTech CEO Paul Johnson Weighs in with an interview with Dr. Erin Stair.
Join us here to go over this past weeks top news stories. We discuss progress in "gravesdisease, a new #cancer smartapp, dedication in finding a cure for #diabetes, #obesity as a chronic illness, #pregnancy and trials involving marijuana, trial site accreditation #acres, and of very serious note #patientsafety and quality, and clinical investigation #turnover.
Articles mentioned "for more information go to TrialSite News" are below:
https://www.trialsitenews.com/md-anderson-issues-plan-of-correction-after-fatal-blood-transfusion/
https://www.trialsitenews.com/fda-approves-pfizers-biosimilar-zirabev-to-roches-avastin/
Time Stamps Below:
Graves’ Disease: 00:25
Cancer Smartphone App ePAL: 02:07
Cancer Trials : 03:22
Diabetes: 05:49
Gastrointestinal: 08:01
Obesity: 09:50
Women’s Health/ Pregnancy: 12:19
Trial Monitoring and Accreditation/ACRES: 13:07
Patient Safety and Quality: 15:56
Clinical Investigation Turnover 19:39
Join our Newsletter-https://mailchi.mp/40c3f67a03e7/trialsitenewsdailydigest
You can follow us at any of these locations:
https://twitter.com/TrialsiteN
https://www.facebook.com/TrialSiteN/
https://www.instagram.com/trialsitenews/
https://www.trialsitenews.com
...
https://www.youtube.com/watch?v=l0St9QZNUNQ
In this podcast we talk with Clark Swanson of #Flavocure Biotech about their flavonoid derivative of #cannabis and its demonstrations in therapeutic potential in preclinical models of metastatic #pancreaticcancer.
Read more here https://www.trialsitenews.com/cannabis-derivative-fbl-03g-represents-significant-therapy-potential-to-treat-pancreatic-cancer/
You can see more at https://www.flavocure.com/
...
https://www.youtube.com/watch?v=QNha6S81h8k
In this podcast Dr. Robert Jeanfreau talks about a range of specifics, from how he got involved in medicine and founded MedPharmics to MedPharmics collaboration with East Jefferson General Hospital to collect blood samples to support clinical trials addressing COVID-19 extreme cases.
You can see more information about Dr. Jeanfreau and MedPharmics https://medpharmics.com/about/
...
https://www.youtube.com/watch?v=fNpn9MbMePQ
In our last episode we met with Dr. Sabine Hazan regarding her #FDA Trials involving #Ivermectin.
It appears that each human, like a fingerprint has a completely different micro biome.
This could explain why Covid-19 acts differently in each subject.
We had more questions.
...
https://www.youtube.com/watch?v=6N9selCrlJY
Join The Conversation! | https://trialsitenews.com/
Founded by Chinese biotech entrepreneur Wei William Cao, Suzhou, China headquartered Gracell Biotechnologies Co., Ltd (Gracell) is on a mission to bring best-in-class and economical cellular medicines to cancer patients. Dedicating capital, talent, and technology to resolve the cellular gene therapy industry’s major challenges including high production costs, lengthy manufacturing process, lack of off-the-shelf products, and short duration of therapeutic effects, the global clinical-stage biopharmaceutical company leverages its pioneering FastCAR and TruUCAR technology platforms. The company recently reported good news: its investigational treatment for multiple myeloma known as GCO12F has been assigned orphan drug status by the U.S. Food and Drug Administration (FDA).
...
https://www.youtube.com/watch?v=HLeEEx1PF3k
Baylor University Medical Center Investigates Safety & Efficacy of Leronlimab in Severe to Critical COVID-19 Patients:
Baylor University Medical Center prepares to initiate a clinical trial investigating leronlimab, an investigational drug for HIV infections that has been under clinical evaluation due to its apparent ability to inhibit lung inflammation associated with COVID-19. With the goal to reduce breathing problems and help patients with severe to critical COVID-19 cases, the prominent Texas academic medical center (and largest not-for-profit health system in Texas) was selected by drug sponsor CytoDyn to participate in an ongoing Phase 3 clinical trial. Northern Texas research sites get busy as well in the fight against COVID-19.
https://www.trialsitenews.com/baylor-university-medical-center-investigates-safety-efficacy-of-leronlimab-in-severe-to-critical-covid-19-patients/
Top California Gastroenterology Investigator Leads Phase 2 Ivermectin Clinical Trial Targeting COVID-19 Cases:
A dynamic research organization in Ventura, California, called Progenabiome, LLC will initiate a Phase 2 clinical trial investigating the efficacy of ivermectin in combination with Doxycycline, much like the successful combination tested by Dr. Tarek Alam from Bangladesh Medical College, in combination with dietary supplements including Zinc, Vitamin D3 and Vitamin C. The study is led by a top principal investigator in California, profiled previously by TrialSite News: Dr. Sabine Hazan.
https://www.trialsitenews.com/top-california-gastroenterology-investigator-leads-phase-2-ivermectin-clinical-trial-targeting-covid-19-cases/
Do the MATH+: COVID-19 Protocol of Steroids and Vitamin C Divides Experts:
A group of critical-care specialists from academic institutions and major hospitals have come together to form the Front Line Covid-19 Critical Care Alliance, and they have developed the MATH+ protocol for hospital treatment of COVID-19. On July 16, Medscape took a look at this protocol. They note that, “response to the protocol among other critical care physicians is mixed, with several physicians, in interviews with Medscape Medical News, urging caution because the benefits and relative risks of the combined medications have not been tested in randomized control trials.” MATH+ is an acronym for “methylprednisolone (a steroid), ascorbic acid (vitamin C), thiamine, and heparin.” The “plus” stands for additional supplements, such as vitamin D, zinc, and melatonin. MATH+ evolved from “HAT therapy” (hydrocortisone, ascorbic acid, and thiamine) that was created by Dr. Paul Marik, chief of the division of pulmonary and critical care medicine at Eastern Virginia Medical School, for critical cases of sepsis.
MATH+, RCTs, and Heresy
https://www.trialsitenew
...
https://www.youtube.com/watch?v=X3gHzBI68dk
This past Friday, Rochelle Walensky, the head of the Centers for Disease Control (CDC) resigned. Her departure comes days before the Biden administration’s declared end to the Covid health emergency. In her resignation letter to the president, Walensky gave no specific reason for her departure but said the country was in a moment of transition as the Covid emergency declarations are ending. No interim director was named, and Walensky will leave the CDC on June 30.. “I have never been prouder of anything I’ve done in my professional career,” Walensky wrote in her resignation letter. In addition to the letter to President Biden, Walensky announced her departure at a CDC staff meeting.
------------------------------------
Join The Conversation! | https://trialsitenews.com/
...
https://www.youtube.com/watch?v=7ZZPzBnyaTI
Join The Conversation! | https://trialsitenews.com/
Jim Reilly is vice president, Vault R&D and Quality at Veeva Systems and recently wrote an opinion piece for TrialSite News called "Overcoming Growing Pains with Decentralized Trials."
Veeva Systems specializes in cloud-based software solutions for the Global Life Sciences Industry, from R&D to Market.
Link | https://www.veeva.com/
...
https://www.youtube.com/watch?v=X2ojgMTB_Mo